Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - atorvastatinum - comprimés pelliculés - atorvastatinum 40 mg ut atorvastatinum calcicum trihydricum 43.40 mg, calcii carbonas, cellulosum microcristallinum, lactosum monohydricum 131.22 mg, carmellosum natricum conexum corresp. natrium 3.24 mg, polysorbatum 80, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, e 171, talcum, simeticonum, polysorbatum 65, methylcellulosum, macrogoli 8 stearas typus i, glyceroli monostearas 40-55, xanthani gummi, acidum benzoicum 0.00024 mg, acidum sorbicum, acidum sulfuricum, cera candelilla, pro compresso obducto. - réduction de la serumcholesterinkonzentration - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - atorvastatinum - comprimés pelliculés - atorvastatinum 80 mg ut atorvastatinum calcicum trihydricum 86.80 mg, calcii carbonas, cellulosum microcristallinum, lactosum monohydricum 262.44 mg, carmellosum natricum conexum corresp. natrium 6.48 mg, polysorbatum 80, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, e 171, talcum, simeticonum, polysorbatum 65, methylcellulosum, macrogoli 8 stearas typus i, glyceroli monostearas 40-55, xanthani gummi, acidum benzoicum 0.00048 mg, acidum sorbicum, acidum sulfuricum, pro compresso obducto. - réduction de la serumcholesterinkonzentration - synthetika

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alfasan nederland b.v. - hyclate de doxycycline 11,547 mg/ml - eq. doxycycline 10 mg/ml - suspension buvable en gouttes - 10 mg/ml - hyclate de doxycycline - doxycycline - chien; chat

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - sirolimusum - solution buvable - sirolimusum 1 mg, polysorbatum 80, phosphatidylcholinum, sojae huile 20 mg, mono/diglycerida, ethanolum 96 pour cent à 20 mg, propylenglycolum 350 mg, e 304, à la solution de 1 ml, ethanolum 3.17 % v/v. - immunsuppressivum - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

doetsch grether ag - de potassium - retardtabletten - kalii chloridum 745.5 mg corresp. kalium 10 mmol corresp. kalium 391 mg, ammonio methacrylatis copolymerum a, ammonio methacrylatis copolymerum b, triethylis citras, silica colloidalis anhydrica, magnesii stearas, talcum, simeticonum, Überzug: talcum, ammonio methacrylatis copolymerum a, ammonio methacrylatis copolymerum b, macrogolum 6000, triethylis citras, e 171, e 132, simeticonum, pro compresso obducto. - kaliumpräparat - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - venlafaxinum - hartkapsel, retardiert - venlafaxinum 150 mg ut venlafaxini hydrochloridum, cellulosum microcristallinum, hypromellosum, ethylcellulosum, talcum, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, e 171, pro capsula. - antidepressivum - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - venlafaxinum - hartkapsel, retardiert - venlafaxinum 150 mg ut venlafaxini hydrochloridum, cellulosum microcristallinum, hypromellosum, ethylcellulosum, talcum, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, e 171, pro capsula. - antidepressivum - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

bridging pharma gmbh - pancreatis pulvis, aspergilli oryzae enzymata - dragées - pancreatis pulvis corresp. lipasum 7400 u. ph. eur. et proteasum 420 u. ph. eur. et amylasum 7000 u. ph. eur., aspergilli oryzae enzymata corresp. proteasum 10 u. fip et amylasum 170 u. fip et cellulasum (1974) 70 u. fip, saccharum 123.3 mg, talcum, cellulosi pulvis, carmellosum natricum conexum corresp. natrium 11.7 mg, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, polyacrylatis dispersio 30 per centum, calcii carbonas, povidonum k 25, titanii dioxidum, glycerolum (85 per centum), acaciae gummi, silica colloidalis anhydrica, triethylis citras, magnesii stearas, macrogolum 8000, simeticonum, macrogolum 35'000, glucosum liquidum 0.8 mg, hypromellosum, cellulosum microcristallinum, calcii lactas pentahydricus, cera carnauba, acidum sorbicum, pro compresso obducto. - digestivum - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - paromomycinum - gélules - paromomycinum 250 mg ut paromomycini sulfas, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), drucktinte: e 171, lacca, propylenglycolum, simeticonum, pro capsula. - infections de l'intestin - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

verfora sa - lidocainum - emulsion cutanée - lidocainum 10 mg, paraffinum liquidum, alcohol stearylicus 23.8 - 27.3 mg, macrogoli aether cetostearylicus, sorbitani stearas, isopropylis myristas, propylenglycolum 30 mg, polysorbatum 60, alcohol cetylicus 12.5 mg, levomentholum, e 218 2 mg, simeticonum, camphora racemica, alcohol benzylicus 1.02 mg, benzethonii chloridum, dinatrii edetas, propylis parahydroxybenzoas 1 mg, geraniolum 0.36 mg, aqua purificata, ad emulsionem pro 1 g. - en cas d'irritation cutanée - synthetika